AZN Share PerformanceMore
|52 week high||5,505.0 05/08/16|
|52 week low||3,680.0 24/06/16|
|52 week change||315.5 (7.37%)|
|4 week volume||70,066,340 24/01/17|
Latest News« previous» nextMore
17/02/2017 - 16:48 StockMarketWire
Marmite owner Unilever (ULVR) rejected a 115bn takeover bid from US rival Kraft Heinz. Management said the offer un...
17/02/2017 - 11:53 StockMarketWire
Sterling struggled following the publication of disappointing UK retail sales, while worldwide markets remained stagnant. ...
17/02/2017 - 09:30 StockMarketWire
Jefferies International today reaffirms its buy investment rating on AstraZeneca PLC (LON:AZN) and raised its price targ...
17/02/2017 - 08:53 StockMarketWire
London blue chips were down an ace in opening deals, but already rising off earlier lows, after key US and Asian indices s...
17/02/2017 - 07:31 StockMarketWire
AstraZeneca has announced positive results from its phase III OLYMPIAD trial comparing Lynparza (olaparib) tablets (30...
17/02/2017 - 07:00 RNS
RNS Number: 1622X AstraZeneca PLC 17 February 2017 This announcement contains inside information 17 February 2017, 07:00 GMT LYNPARZA MEETS PRIMARY ENDPOINT IN PHASE III TRIAL IN BRCA -MUTATED METASTATIC BREAST CANCER Lynparza provided a statistically-significant improvement in progression-free survival compared to ch...
16/02/2017 - 16:51 StockMarketWire
Oil prices remained stagnant throughout the day, preventing sector giants Royal Dutch Shell (RDSB) and BP (BP.) from gi...
16/02/2017 - 16:43 Interactive Investor
After a poor 2016, star fund manager Neil Woodford lagged the wider market again in January. He's also been bargain hu...
Latest discussion posts More
“Have you not heard? Under the mattress offers a yield of 10%, but don't tell write a block about it. It's our little secret. Also little know fact; if it's a king size double ...”▼
“First of the new pipeline drugs, treatment for breast cancer, has positive trial results producing a significant effect. So let's hope that this is just the start of the new ...”▼
“write a block, with all due respect please don't be such a pompous clot. The fact that Astrazeneca fell yesterday mostly, in all probability, because it went ex-dividend is ...”▼
Codes & Symbols
|Symbols||AZN, LSE:AZN, AZN.L, AZN:LN, LON:AZN, XLON:AZN|